Biomed Group
Contributor since: 2013
Latest Articles
Vital Therapies Stands To Benefit From The High Unmet Need In Treating ALF Patients
EnteroMedics: Recent Sell-Off In Biotech Creates A Great Entry Opportunity
GlycoMimetics: A Promising Sickle Cell Disease Play
Fibrocell Science: An Attractive Healthcare Investment
Chimerix: A Significant Player In The Antiviral Therapeutics Market
Aratana Therapeutics: A Growing Player Within The Emerging Pet Therapeutics Market
Five Prime: A Growing Oncology And Inflammatory Player With A Promising Pipeline
Heat Biologics: An Undervalued Cancer Vaccine Play That Leaves Considerable Room For Upside
Alphatec Holdings: An Undervalued Spine Player With A Potential Growth Opportunity
NanoString: An Exciting Small Cap Story With A Strong Growth Outlook
Verastem: An Attractive Long-Term Investment In The Cancer Stem Cell Space
Alcobra: An Interesting Investment Opportunity In The Healthcare Space
Insys Therapeutics: A Profitable Pharmaceutical Company With Great Potential Growth
Galena Biopharma: Promising Pipeline Points To A Bright Future
KaloBios: An Undervalued Pharmaceutical Company With Remarkable Pipeline
MEI Pharma: The Good And The Bad
Amicus Therapeutics: The Good And The Bad
Onyx Pharmaceuticals: Kyprolis Is The Key Driver Of Future Growth
OncoGenex: SYNERGY Trial Is The Major Catalyst In Sight
Medivation: Early Launch Of Xtandi Appears Solid
Dynavax Technologies: Key Issues To Consider
Omeros Corporation's Stock Has Potential To Double This Year
Amgen: A Long-Term Growth Story
FISSION Study Should Support Regulatory Approval For Gilead's Hepatitis C Drug